// App-Quantinova.ai

TCT-644 : Use of New Thienopyridines in Patients with Coronary Artery Disease Treated with Percutaneous Coronary Interventions in Argentina. Results From A “Real World” Multicenter Registry

Researchers

Presenter

  • Alfredo Rodriguez Granillo

Principal Investigators

  • Carlos Haiek

  • Miguel Larribau

  • Carlos Fernandez Pereira

  • Juan Mieres

  • Ricardo Sarmiento

  • YingBing Pan

  • Ming Zheng

  • Antonio Pocovi

  • Alfredo Rodriguez

Medical Centers

  • Sanatorio Otamendi y Miroli, Ciudad de Buenos Aires, Argentina

  • Sanatorio Otamendi, Buenos Aires, Argentina, Buenos Aires, Argentina

  • Hospital en red El Cruce, Buenos Aires, Argentina

  • Shanghai Microport, Shanghai, Shanghai, China

  • trinidad quilmes, Quilmes, Argentina

  • otamendi hospital, buenos aires, Argentina

  • Hospital Espanol de Mendoza, Mendoza, Argentina

  • Sanatorio San Lucas, Buenos Aires, Argentina

Locations

  • Argentina

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Central Nervous System (CNS)

  • Nephrology

  • Blood/haematological Diseases

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Left main disease

  • Renal insufficiency

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved